Future for ovarian cancer screening: novel markers from emerging technologies of transcriptional profiling and proteomics.
Mills
G B
GB
Bast
R C
RC
Srivastava
S
S
D000368:Aged; D014408:Biomarkers, Tumor / Q000032:analysis* / Q000592:standards; D018394:CA-125 Antigen / Q000032:analysis; D003402:Creatine Kinase / Q000032:analysis* / Q000235:genetics; D018450:Disease Progression; D005260:Female; D020869:Gene Expression Profiling / Q000379:methods*; D006801:Humans; D008403:Mass Screening / Q000379:methods*; D008875:Middle Aged; D009363:Neoplasm Proteins / Q000032:analysis* / Q000235:genetics; D020411:Oligonucleotide Array Sequence Analysis; D009857:Oncogenes; D009928:Organ Specificity; D053495:Osteopontin; D010051:Ovarian Neoplasms / Q000175:diagnosis* / Q000235:genetics / Q000378:metabolism; D011237:Predictive Value of Tests; D012333:RNA, Messenger / Q000032:analysis; D012334:RNA, Neoplasm / Q000032:analysis; D012680:Sensitivity and Specificity; D012697:Serine Endopeptidases / Q000032:analysis* / Q000235:genetics; D012795:Sialoglycoproteins / Q000032:analysis* / Q000235:genetics; D014158:Transcription, Genetic; D014407:Tumor Cells, Cultured / Q000737:chemistry; D000099271:Prostasin
D014408:Biomarkers, Tumor; D018394:CA-125 Antigen; D003402:Creatine Kinase; D009363:Neoplasm Proteins; D053495:Osteopontin; D012333:RNA, Messenger; D012334:RNA, Neoplasm; D012697:Serine Endopeptidases; D012795:Sialoglycoproteins; D000099271:Prostasin; C506895:SPP1 protein, human